Wells Fargo’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,945
Closed -$78K 7907
2022
Q2
$78K Sell
4,945
-9,287
-65% -$142K ﹤0.01% 4793
2022
Q1
$216K Sell
14,232
-17,537
-55% -$267K ﹤0.01% 4937
2021
Q4
$489K Buy
31,769
+13,675
+76% +$180K ﹤0.01% 4683
2021
Q3
$158K Buy
18,094
+6,464
+56% +$58.9K ﹤0.01% 5200
2021
Q2
$119K Sell
11,630
-68,141
-85% -$719K ﹤0.01% 5238
2021
Q1
$953K Sell
79,771
-30,593
-28% -$347K ﹤0.01% 4282
2020
Q4
$1M Sell
110,364
-128,461
-54% -$994K ﹤0.01% 4021
2020
Q3
$1.46M Sell
238,825
-56,594
-19% -$432K ﹤0.01% 3572
2020
Q2
$2.62M Buy
295,419
+265,514
+888% +$2.29M ﹤0.01% 3056
2020
Q1
$217K Sell
29,905
-667
-2% -$4.94K ﹤0.01% 4632
2019
Q4
$269K Sell
30,572
-94,055
-75% -$704K ﹤0.01% 4790
2019
Q3
$759K Buy
124,627
+46,934
+60% +$264K ﹤0.01% 4055
2019
Q2
$324K Sell
77,693
-2,780
-3% -$14.7K ﹤0.01% 4678
2019
Q1
$506K Buy
80,473
+6,832
+9% +$47.9K ﹤0.01% 4322
2018
Q4
$478K Buy
73,641
+16,435
+29% +$126K ﹤0.01% 4367
2018
Q3
$475K Buy
57,206
+744
+1% +$5.66K ﹤0.01% 4477
2018
Q2
$351K Buy
56,462
+38,314
+211% +$244K ﹤0.01% 4708
2018
Q1
$125K Sell
18,148
-46,707
-72% -$297K ﹤0.01% 5214
2017
Q4
$427K Buy
64,855
+21,238
+49% +$130K ﹤0.01% 4507
2017
Q3
$242K Buy
43,617
+19,088
+78% +$129K ﹤0.01% 4825
2017
Q2
$189K Sell
24,529
-24,313
-50% -$205K ﹤0.01% 4824
2017
Q1
$441K Sell
48,842
-15,777
-24% -$164K ﹤0.01% 4327
2016
Q4
$698K Buy
64,619
+11,115
+21% +$148K ﹤0.01% 3965
2016
Q3
$874K Sell
53,504
-21,734
-29% -$306K ﹤0.01% 3572
2016
Q2
$717K Sell
75,238
-3,128
-4% -$34.1K ﹤0.01% 3695
2016
Q1
$1.1M Sell
78,366
-26,028
-25% -$269K ﹤0.01% 3350
2015
Q4
$1.13M Buy
104,394
+102,400
+5,135% +$926K ﹤0.01% 3403
2015
Q3
$14K Sell
1,994
-704
-26% -$5.45K ﹤0.01% 5640
2015
Q2
$25K Buy
+2,698
New +$20.5K ﹤0.01% 5535
2014
Q4
Sell
-200
Closed -$1K 6489
2014
Q3
$1K Buy
+200
New +$624 ﹤0.01% 6111

Other funds holding NPTN

Wells Fargo's NPTN Position: Q3 2022 in Review

Wells Fargo sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 4,945 shares — an estimated $78K sold.

Wells Fargo first reported a position in NPTN in Q3 2014 and held it in 30 quarters. The position peaked at $2.62M in Q2 2020. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

  • Wells Fargo reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
  • Wells Fargo sold 4,945 NEOPHOTONICS CORP shares in Q3 2022, an estimated $78K.
  • Wells Fargo first reported a position in NEOPHOTONICS CORP in Q3 2014 and held it in 30 quarters.
  • Wells Fargo's NEOPHOTONICS CORP position peaked at $2.62M in Q2 2020.
  • 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Wells Fargo's 13F filing for Q3 2022, filed 14 Nov 2022.